Application 125319

Type
BLA
Sponsor
NOVARTIS PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ILARISCANAKINUMABINJECTABLE; SUBCUTANEOUS180MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0078-0582IlariscanakinumabNovartis Pharmaceuticals CorporationBLACurrent
0078-0582IlariscanakinumabNovartis Pharmaceuticals CorporationBLACurrent
0078-0734IlariscanakinumabNovartis Pharmaceuticals CorporationBLACurrent
0078-0734IlariscanakinumabNovartis Pharmaceuticals CorporationBLACurrent
0078-0734IlariscanakinumabNovartis Pharmaceuticals CorporationBLACurrent
0078-0734IlariscanakinumabNovartis Pharmaceuticals CorporationBLACurrent
0078-0734IlariscanakinumabNovartis Pharmaceuticals CorporationBLACurrent
0078-0734IlariscanakinumabNovartis Pharmaceuticals CorporationBLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
80145SUPPL 2024-11-05
80144SUPPL 2024-11-05
80120SUPPL 2024-11-05
75312SUPPL 2023-08-29
75300SUPPL 2023-08-28
64650SUPPL2020-09-22
64649SUPPL2020-09-22
64625SUPPL2020-09-21
63605SUPPL2020-06-17
63604SUPPL2020-06-17
63594SUPPL2020-06-17
56359SUPPL2018-11-08
50941SUPPL2017-12-29
50940SUPPL2017-12-29
50939SUPPL2017-12-29
46525SUPPL2016-12-23
46510SUPPL2016-12-22
45393SUPPL2016-09-27
45392SUPPL2016-09-27
45391SUPPL2016-09-27
45399SUPPL2016-09-26
45398SUPPL2016-09-26
45397SUPPL2016-09-26
9697SUPPL2016-07-26
39918SUPPL2016-07-22
39917SUPPL2014-10-21
9696SUPPL2014-10-21
43932ORIG2013-05-15
39916SUPPL2013-05-13
9695SUPPL2013-05-13
31920SUPPL2012-10-15
39915SUPPL2012-10-12
31919SUPPL2012-04-02
18861SUPPL2012-04-02
44800ORIG2009-08-26
43318ORIG2009-08-26
31918ORIG2009-06-30
18860ORIG2009-06-29